| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SCI Pharmtech Inc (TW: 4119)
4119 Technical Analysis
5
| As on 3rd Dec 2025 4119 STOCK Price closed @ 48.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 71.63 & Strong Sell for SHORT-TERM with Stoploss of 89.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4119STOCK Price
| Open | 49.35 | Change | Price | % |
| High | 49.35 | 1 Day | -1.00 | -2.03 |
| Low | 48.35 | 1 Week | 0.90 | 1.90 |
| Close | 48.35 | 1 Month | -9.95 | -17.07 |
| Volume | 61371 | 1 Year | -46.65 | -49.11 |
| 52 Week High 97.80 | 52 Week Low 47.00 | ||||
TW Taiwan Most Active Stocks
| 2888 | 11.80 | 3.96% |
| 1303 | 67.70 | 5.12% |
| 1802 | 35.90 | -3.23% |
| 2408 | 151.00 | 1.00% |
| 2344 | 55.80 | -1.41% |
| 8110 | 39.15 | -0.63% |
| 2337 | 32.80 | -2.09% |
| 3481 | 14.20 | 1.43% |
| 2409 | 11.65 | 2.64% |
| 8039 | 79.30 | -2.10% |
TW Taiwan Top Gainers Stocks
TW Taiwan Top Losers Stocks
| 4119 Daily Charts |
4119 Intraday Charts |
Whats New @ Bazaartrend |
4119 Free Analysis |
|
|
4119 Important Levels Intraday
| RESISTANCE | 50.28 |
| RESISTANCE | 49.66 |
| RESISTANCE | 49.28 |
| RESISTANCE | 48.90 |
| SUPPORT | 47.81 |
| SUPPORT | 47.42 |
| SUPPORT | 47.04 |
| SUPPORT | 46.42 |
4119 Forecast December 2025
| 4th UP Forecast | 79.18 |
| 3rd UP Forecast | 69.29 |
| 2nd UP Forecast | 63.18 |
| 1st UP Forecast | 57.07 |
| 1st DOWN Forecast | 39.63 |
| 2nd DOWN Forecast | 33.52 |
| 3rd DOWN Forecast | 27.41 |
| 4th DOWN Forecast | 17.52 |
4119 Weekly Forecast
| 4th UP Forecast | 59.14 |
| 3rd UP Forecast | 55.68 |
| 2nd UP Forecast | 53.54 |
| 1st UP Forecast | 51.40 |
| 1st DOWN Forecast | 45.30 |
| 2nd DOWN Forecast | 43.16 |
| 3rd DOWN Forecast | 41.02 |
| 4th DOWN Forecast | 37.56 |
4119 Forecast2025
| 4th UP Forecast | 147.78 |
| 3rd UP Forecast | 115.89 |
| 2nd UP Forecast | 96.18 |
| 1st UP Forecast | 76.47 |
| 1st DOWN Forecast | 20.23 |
| 2nd DOWN Forecast | 0.52 |
| 3rd DOWN Forecast | -19.19 |
| 4th DOWN Forecast | -51.08 |
SCI Pharmtech Inc ( TW Taiwan Symbol : 4119 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4119 Other Details
| Segment | EQ | |
| Market Capital | 7487518208.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > echo $website ; ?> | |
4119 Address
![]() |
||
4119 Latest News
4119 Business Profile
SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and custom products worldwide. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Clindamycin Palmitate HCl, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate, Thiopental, Valproic Acid, Adenine, Cannabidiol, and Dexmethylphenidate HCl. The company's intermediate products comprise Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Diethyl dipropylmalonate, Diethyl ethyl(1-methylbutyl)malonate, Pyrogallolaldehyde, Benzhydrylamine, 1-Benzhydrylazetidin-3-ol, 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one, N-Methyl-4-piperidinol, Ritalinic acid, d-Ritalinic acid HCl, (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol HCl, and (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol. Its intermediate products also consists of (S)-3-(methylmino)-1-(2-thi-enyl)propan-1-ol, (R)-3-(Methylamino)-1-phenylpropanol, (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, Menthadienol, 5-pentylbenzene-1,3-diol Olivetol, Methyl 2,4-dihydroxy-6-pentylbenzoate, and Ethyl 2,4-dihydroxy-6-pentylbenzoate Ethyl Olivetolate. The company also provides custom manufacturing services. SCI Pharmtech, Inc. was founded in 1987 and is based in Taoyuan City, Taiwan. Address: No. 61, Haihu North Road, Taoyuan City, Taiwan, 33856
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

